SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001493152-24-017464
Filing Date
2024-05-02
Accepted
2024-05-01 19:22:43
Documents
83

Document Format Files

Seq Description Document Type Size
1 formposam.htm   iXBRL POS AM 3121432
2 ex23-1.htm EX-23.1 3943
3 forms-1_001.jpg GRAPHIC 6470
  Complete submission text file 0001493152-24-017464.txt   11191469

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cdt-20231231.xsd EX-101.SCH 73606
5 XBRL CALCULATION FILE cdt-20231231_cal.xml EX-101.CAL 75712
6 XBRL DEFINITION FILE cdt-20231231_def.xml EX-101.DEF 312813
7 XBRL LABEL FILE cdt-20231231_lab.xml EX-101.LAB 503597
8 XBRL PRESENTATION FILE cdt-20231231_pre.xml EX-101.PRE 413172
87 EXTRACTED XBRL INSTANCE DOCUMENT formposam_htm.xml XML 1966154
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-275056 | Film No.: 24904652
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)